Clare Brennan

2.2k total citations · 2 hit papers
20 papers, 1.6k citations indexed

About

Clare Brennan is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Clare Brennan has authored 20 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 8 papers in Virology and 6 papers in Epidemiology. Recurrent topics in Clare Brennan's work include HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (8 papers) and Cytomegalovirus and herpesvirus research (5 papers). Clare Brennan is often cited by papers focused on HIV Research and Treatment (8 papers), HIV/AIDS drug development and treatment (8 papers) and Cytomegalovirus and herpesvirus research (5 papers). Clare Brennan collaborates with scholars based in United States, United Kingdom and Germany. Clare Brennan's co-authors include Sherene Min, François Raffi, Bonaventura Clotet, Jan van Lunzen, Judith Feinberg, Anita Rachlis, Julia Harris, Chloe Orkin, W. D. Hardy and Mark Bloch and has published in prestigious journals such as The Lancet, Clinical Infectious Diseases and The Journal of Infectious Diseases.

In The Last Decade

Clare Brennan

19 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

2013 404 citations François Raffi, Anita Rachlis et al. The Lancet profile →
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study

2014 350 citations Bonaventura Clotet, Judith Feinberg et al. The Lancet profile →

Peers

Clare Brennan

VIROL

EPIDE

Nicola Gianotti Italy

Nicoletta Ladisa Italy

Cindy Vavro United States

Hans-Jürgen Stellbrink Germany

Peter Gute Germany

Moti Ramgopal United States

Christina M. Lalama United States

Rachael Jones United Kingdom

Aza Rakhmanova Russia

Erin Quirk United States

Nicola Gianotti Italy

Clare Brennan

1.2k ×0.9

1.1k ×1.1

VIROL

305 ×0.9

306 ×1.0

EPIDE

133 ×0.7

Citations per year, relative to Clare Brennan Clare Brennan (= 1×) peers Nicola Gianotti

Countries citing papers authored by Clare Brennan

Since Specialization

Citations

This map shows the geographic impact of Clare Brennan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Brennan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Brennan more than expected).

Fields of papers citing papers by Clare Brennan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Brennan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Brennan. The network helps show where Clare Brennan may publish in the future.

Co-authorship network of co-authors of Clare Brennan

This figure shows the co-authorship network connecting the top 25 collaborators of Clare Brennan. A scholar is included among the top collaborators of Clare Brennan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Clare Brennan. Clare Brennan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Brennan, Clare, et al.. (2020). Play and the Exhibition: The problematic fun of showcasing of videogames in informal and formal contexts. Electronic workshops in computing. 1 indexed citations

Himmerich, Hubertus, et al.. (2019). Facets of shared decision-making on drug treatment for adults with an eating disorder. International Review of Psychiatry. 31(4). 332–346. 12 indexed citations

Trottier, Benoît, Jordan E. Lake, Cynthia Brinson, et al.. (2016). Dolutegravir/Abacavir/Lamivudine versus Current ART in Virally Suppressed Patients (STRIIVING): A 48-Week, Randomized, Non-Inferiority, Open-Label, Phase IIIb Study. Antiviral Therapy. 22(4). 295–305. 82 indexed citations

Cook, Sarah & Clare Brennan. (2016). All Watched Over by Machines of Loving Grace: NEoN Digital Arts Festival Exhibition. ENLIGHTEN (Jurnal Bimbingan dan Konseling Islam). 1 indexed citations

Molina, Jean‐Michel, Bonaventura Clotet, Jan van Lunzen, et al.. (2015). Once-daily dolutegravir versus darunavir plus ritonavir for treatment-naive adults with HIV-1 infection (FLAMINGO): 96 week results from a randomised, open-label, phase 3b study. The Lancet HIV. 2(4). e127–e136. 152 indexed citations

Clotet, Bonaventura, Judith Feinberg, Jan van Lunzen, et al.. (2014). Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study. The Lancet. 383(9936). 2222–2231. 350 indexed citations breakdown →

Molina, Jean‐Michel, Bonaventura Clotet, Jan van Lunzen, et al.. (2014). Once‐daily dolutegravir is superior to once‐daily darunavir/ritonavir in treatment‐naïve HIV‐1‐positive individuals: 96 week results from FLAMINGO. Journal of the International AIDS Society. 17(4S3). 19490–19490. 35 indexed citations

Raffi, François, Anita Rachlis, Cynthia Brinson, et al.. (2014). Dolutegravir efficacy at 48 weeks in key subgroups of treatment-naive HIV-infected individuals in three randomized trials. AIDS. 29(2). 167–174. 43 indexed citations

Brennan, Clare & Lynn Parker. (2014). Animating Dance and Dancing with Animation: A Retrospective of Forever Falling Nowhere. Electronic workshops in computing. 4 indexed citations

10.

Biddle, Nicholas, Clare Brennan, & Mandy Yap. (2014). Effectiveness of traineeships and apprenticeships for the Aboriginal and Torres Strait Islander population. ANU Open Research (Australian National University). 1 indexed citations

11.

Raffi, François, Anita Rachlis, Hans‐Jürgen Stellbrink, et al.. (2013). Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study. The Lancet. 381(9868). 735–743. 404 indexed citations breakdown →

12.

Raffi, François, Hans Jaeger, Eugenia Quirós-Roldán, et al.. (2013). Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial. The Lancet Infectious Diseases. 13(11). 927–935. 269 indexed citations

13.

Eron, Joseph, Anton Pozniak, Julian Elliott, et al.. (2012). Dolutegravir treatment response by baseline viral load and NRTI backbone in treatment‐naïve HIV‐infected individuals. Journal of the International AIDS Society. 15(S4). 1–1. 5 indexed citations

14.

Martens, Mark G., Kenneth H. Fife, Peter A. Leone, Lynn P. Dix, & Clare Brennan. (2009). Once Daily Valacyclovir for Reducing Viral Shedding in Subjects Newly Diagnosed with Genital Herpes. Infectious Diseases in Obstetrics and Gynecology. 2009. 1–7. 9 indexed citations

15.

Sperling, Rhoda, Kenneth H. Fife, Terri Warren, Lynn P. Dix, & Clare Brennan. (2008). The Effect of Daily Valacyclovir Suppression on Herpes Simplex Virus Type 2 Viral Shedding in HSV-2 Seropositive Subjects Without a History of Genital Herpes. Sexually Transmitted Diseases. 35(3). 286–290. 15 indexed citations

16.

Becker, Stephen, Gregory Fusco, Jennifer S Fusco, et al.. (2004). HIV‐Associated Thrombotic Microangiopathy in the Era of Highly Active Antiretroviral Therapy: An Observational Study. Clinical Infectious Diseases. 39(s5). S267–S275. 68 indexed citations

17.

Warren, Terri, Julia Harris, & Clare Brennan. (2004). Efficacy and Safety of Valacyclovir for the Suppression and Episodic Treatment of Herpes Simplex Virus in Patients with HIV. Clinical Infectious Diseases. 39(s5). S258–S266. 19 indexed citations

18.

DeJesus, Edwin, Anna Wald, Terri Warren, et al.. (2003). Valacyclovir for the Suppression of Recurrent Genital Herpes in Human Immunodeficiency Virus–Infected Subjects. The Journal of Infectious Diseases. 188(7). 1009–1016. 53 indexed citations

19.

Brennan, Clare, et al.. (1999). Consuming Passions: Groups for Women with Eating Problems. Group Analysis. 32(1). 37–51. 9 indexed citations

20.

Brennan, Clare, et al.. (1998). The pharmacokinetics and metabolism of ifosfamide during bolus and infusional administration: a randomized cross-over study. British Journal of Cancer. 77(6). 978–984. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact